Clinical trial
Determining the Optimal Treatment Strategy for Patients Who Have Chronic Migraine With Medication Overuse
NCT02764320 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Determining the Optimal Treatment Strategy for Patients Who Have Chronic Migraine With Medication Overuse
- Lead sponsor
- Mayo Clinic
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 9, 2017
- Completion date
- March 31, 2021
- Enrollment
- 720 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.
migraine